NCT02965859 - The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2018

Conditions

Chronic Hepatitis B

Interventions

DRUG

Metacavir Enteric-coated Capsules 80mg

DRUG

Metacavir Enteric-coated Capsules 160mg

DRUG

Metacavir Enteric-coated Capsules 320mg

DRUG

Metacavir Enteric-coated Capsules Placebo 240mg

DRUG

Metacavir Enteric-coated Capsules Placebo 160mg

DRUG

Metacavir Enteric-coated Capsules Placebo 320mg

DRUG

Adefovir Dipivoxil Capsule10mg

DRUG

Adefovir Dipivoxil Capsule Placebo 10mg

Trial Locations (1)

RECRUITING

81 Military Hospital of China, Nanjing